Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
475 GBX | 0.00% |
|
0.00% | +30.14% |
Apr. 24 | EDX Medical to begin trading on Apex segment of AQSE next week | AN |
Apr. 23 | Marula reaches "significant milestone" for Tanzanian graphite projects | AN |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The firm trades with high earnings multiples: 26.1 times its 2023 earnings per share.
- The company's enterprise value to sales, at 4.84 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Financial & Commodity Market Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+30.14% | 160M | - | ||
-6.40% | 70.44B | B | ||
+14.78% | 21.62B | C+ | ||
+23.20% | 12.22B | C+ | ||
+28.59% | 7.59B | C+ | ||
-10.48% | 7.48B | B- | ||
+24.21% | 4.44B | C | ||
-6.47% | 2.79B | C+ | ||
+22.19% | 2.37B | C | ||
+6.95% | 1.9B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AQX Stock
- Ratings Aquis Exchange PLC